Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
www.mendelspod.com
There’s a new genome editing company that everyone is talking about this year. Tome Biosciences came out of stealth in December, claiming the ability to insert DNA sequences of any size at any location across in vivo and ex vivo modalities. Their website says they’re “taking us into the final chapter of medicine.”Tome’s CEO, Rahul Kakkar, joins us today on the program.
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
Taking Gene Therapy to the Next Level: Rahul…
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
There’s a new genome editing company that everyone is talking about this year. Tome Biosciences came out of stealth in December, claiming the ability to insert DNA sequences of any size at any location across in vivo and ex vivo modalities. Their website says they’re “taking us into the final chapter of medicine.”Tome’s CEO, Rahul Kakkar, joins us today on the program.